Polyneuropathy, inflammatory demyelinating, chronic
Clinical trials for Polyneuropathy, inflammatory demyelinating, chronic explained in plain language.
Never miss a new study
Get alerted when new Polyneuropathy, inflammatory demyelinating, chronic trials appear
Sign up with your email to follow new studies for Polyneuropathy, inflammatory demyelinating, chronic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control By invitation onlyThis study is a long-term extension of earlier trials testing the drug riliprubart in adults with CIDP, a condition where the immune system attacks the nerves, causing weakness and numbness. About 300 participants who completed a prior riliprubart study will continue receiving th…
Matched conditions: POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
New hope for tough nerve disease: experimental drug riliprubart enters final testing
Disease control OngoingThis study tests a drug called riliprubart in 140 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that hasn't improved with standard care. Participants receive either riliprubart or a placebo for up to 111 weeks. The main goal is to see if the drug reduces di…
Matched conditions: POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC